Despite entering its maturation phase, the recombinant protein sector will continue to drive the growth of medical biotechnology over the next six years. You have full access to this article via ...

After figuring out how to grow recombinant bacteria on an industrial scale and how to harvest the insulin they produce, it was time to bring the recombinant insulin to the market. In 1982 Food and ...

Their subject was the new technology of recombinant DNA — molecules created in a laboratory by stitching together genetic material from different organisms. Researchers were excited by the ...

The Global Recombinant DNA Technology Market was valued at approximately USD $$ billion in 2022 and is expected to grow at a healthy CAGR of over $% from 2023 to 2030. Recombinant DNA Technology ...

The Global Antibody and Recombinant Protein Contract Development and Manufacturing Organization (CDMO) Market is witnessing remarkable growth, driven by the increasing demand for biologics and ...

Proteintech has designed recombinant antibodies featuring the company's FcZero backbone, engineered to silence the Fc domain ...

Research Tools: Recombinant antibodies are used in the study of cellular pathways, protein-protein interactions, and molecular mechanisms. Regenerative Medicine: Many researchers are now working ...

NewBiologix, a technology innovation company pioneering efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, today released a scientific white paper outlining ...

Recombinant proteins may also have compromised structural integrity due to the presence of protease in the apoplast. To evade this complication, co-expression of a protease inhibitor is ...

coli expression system. It serves as a comprehensive solution for the development and manufacturing of non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for clients across the ...

coli expression system. It serves as a comprehensive solution for the development and manufacturing of non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for clients across the ...